Description
Xtane 25mg (Exemestane 25mg) Tablets
Xtane 25mg contains exemestane 25mg, an aromatase inhibitor used in certain hormone-sensitive breast cancer settings. Exemestane lowers estrogen production in the body, which can help slow the growth of some breast cancer cells that depend on estrogen.
Xtane 25mg is a prescription medicine. Therefore, treatment should follow the advice of an appropriate healthcare professional. The exact treatment plan depends on cancer type, treatment history, menopausal status, and other clinical factors.
What is Xtane 25mg?
Xtane 25mg is an oral tablet containing exemestane 25mg. The product shown contains 30 tablets and is marketed by Natco Pharma Ltd. in India. Current Indian medicine listings identify exemestane 25mg as the active ingredient.
Exemestane belongs to a medicine class called aromatase inhibitors. Unlike some other hormone therapies, exemestane permanently inhibits the aromatase enzyme. As a result, the body produces less estrogen.
What Is Exemestane Used For?
Exemestane is used for certain breast cancer treatment settings. Current U.S. labeling for Aromasin includes adjuvant treatment of postmenopausal patients with estrogen-receptor-positive early breast cancer after 2 to 3 years of tamoxifen, followed by exemestane to complete a total of 5 consecutive years of hormonal therapy.
In addition, the U.S. label includes treatment of advanced breast cancer in postmenopausal patients whose disease progressed after tamoxifen.
Medical teams may consider other factors before choosing an aromatase inhibitor. Therefore, Xtane 25mg should not be used for self-directed cancer treatment.
How Does Exemestane Work?
Exemestane is a steroidal aromatase inhibitor. Aromatase helps convert certain hormones into estrogen.
Exemestane binds irreversibly to the aromatase enzyme and reduces estrogen production. Consequently, lower estrogen levels can reduce hormonal stimulation of some breast cancer cells.
Xtane 25mg Composition
- Active ingredient: Exemestane
- Strength: 25mg
- Dosage form: Tablet
- Product: Xtane 25mg
- Marketer/manufacturer: Natco Pharma Ltd.
- Pack shown: 30 tablets
What is the Exemestane 25mg Dose?
For the approved U.S. Aromasin indications, the recommended dose is 25mg once daily after a meal. Taking the medicine after food improves absorption and helps maintain appropriate drug exposure.
However, the appropriate treatment schedule depends on the clinical situation. Certain medicines that strongly induce CYP3A4 can reduce exemestane exposure. In that situation, the U.S. label recommends 50mg once daily after a meal.
Do not increase or decrease the dose without medical advice.
How Should Xtane 25mg Be Taken?
- Take Xtane exactly as prescribed.
- Take it once daily when your treatment plan calls for daily dosing.
- Take the tablet after a meal.
- Try to take it at approximately the same time each day.
- Swallow the tablet according to your prescription instructions.
- Do not change the dose without speaking with your healthcare professional.
Consistency matters during long-term hormonal treatment. Therefore, follow the schedule provided by your oncology team.
What Are the Side Effects of Exemestane?
Exemestane side effects can vary between individuals. Commonly reported effects include hot flashes, sweating, tiredness, joint or muscle discomfort, headache, and sleep difficulties.
Because exemestane reduces estrogen levels, it can also affect bone health. Consequently, long-term treatment may require monitoring of bone mineral density.
Common Exemestane Side Effects
- Hot flashes
- Increased sweating
- Joint pain
- Muscle pain
- Headache
- Tiredness
- Insomnia or sleep difficulties
- Nausea
- Increased appetite in some people
Tell your healthcare professional if side effects persist or interfere with daily activities.
Serious Exemestane Side Effects
Some adverse effects require prompt medical attention. For example, severe allergic reactions can cause swelling, breathing difficulty, or a widespread rash.
Exemestane can also reduce bone mineral density. Therefore, people receiving long-term therapy may need a bone-health assessment based on their individual risk.
Contact your healthcare professional promptly if you experience severe or unexpected symptoms.
Exemestane and Bone Health
Estrogen contributes to maintaining bone strength. Since exemestane lowers estrogen levels, treatment can increase the risk of bone loss in some patients.
Your healthcare professional may assess bone mineral density before and during treatment. In addition, calcium, vitamin D, exercise, and other bone-health measures may be discussed when appropriate.
People with osteoporosis or a high fracture risk should tell their healthcare professional before starting treatment.
Exemestane and Vitamin D
Low vitamin D can contribute to poor bone health. Therefore, your healthcare professional may check vitamin D status when clinically appropriate.
Do not start high-dose vitamin D or calcium supplements without discussing them with your healthcare team.
Exemestane vs Anastrozole
Exemestane and anastrozole are both aromatase inhibitors. However, they have different chemical structures and pharmacologic properties.
Exemestane is a steroidal, irreversible aromatase inhibitor. Anastrozole is a nonsteroidal aromatase inhibitor. Both can reduce estrogen production, but the best option depends on the individual treatment plan.
For that reason, patients should not switch between exemestane and anastrozole without medical guidance.
Exemestane vs Letrozole
Exemestane and letrozole both reduce estrogen production through aromatase inhibition. Nevertheless, they belong to different chemical subclasses.
Exemestane is steroidal and irreversible, while letrozole is nonsteroidal. Your oncology team can determine which treatment fits your clinical history.
Exemestane vs Tamoxifen
Tamoxifen and exemestane work differently. Tamoxifen blocks estrogen receptors, whereas exemestane reduces estrogen production.
In some treatment plans, people receive tamoxifen first and later switch to exemestane. In fact, the U.S. Aromasin label specifically includes switching to exemestane after 2 to 3 years of tamoxifen to complete 5 years of adjuvant hormonal therapy in an approved early breast cancer setting.
Can Exemestane Be Used With Other Cancer Medicines?
Exemestane may form part of a broader cancer treatment plan. Depending on the disease, an oncology team may consider endocrine therapy alongside other medicines.
Examples of medicines or treatment classes that may arise in breast cancer care include:
- Tamoxifen
- Anastrozole
- Letrozole
- Fulvestrant
- Palbociclib
- Ribociclib
- Abemaciclib
- Everolimus
However, these medicines are not interchangeable. Your oncologist should determine which combination or sequence is appropriate.
Exemestane Drug Interactions
Tell your healthcare professional about all prescription medicines, over-the-counter products, vitamins, and herbal supplements that you use.
Strong CYP3A4 inducers can reduce exemestane exposure. Examples can include certain anticonvulsants and rifampin. Therefore, review your complete medication list before treatment begins.
Also, do not start herbal products such as St. John’s wort without professional advice.
Who Should Tell Their Doctor Before Taking Exemestane?
Tell your healthcare professional if you have:
- Osteoporosis or low bone density
- A history of fractures
- Liver disease
- Kidney disease
- Allergies to medicines
- Other ongoing medical conditions
In addition, provide a complete list of medicines and supplements that you use.
Exemestane and Pregnancy
Tell your healthcare professional if you are pregnant, planning a pregnancy, or may become pregnant.
Exemestane is not intended for use during pregnancy. The medicine can cause fetal harm based on its pharmacologic effects and available safety information.
People who may become pregnant should discuss appropriate contraception and pregnancy planning with their healthcare professional before treatment.
Exemestane and Breastfeeding
Tell your healthcare professional if you are breastfeeding or planning to breastfeed.
Because exemestane can have significant hormonal effects, medical guidance is important before breastfeeding during or after treatment.
Can Exemestane Be Used Before Menopause?
Exemestane is primarily used in postmenopausal breast cancer treatment settings. Therefore, it should not be used before menopause unless a specialist has specifically established an appropriate treatment plan.
Menopausal status can affect the choice and effectiveness of endocrine therapy. Your oncology team should confirm the appropriate treatment strategy.
What Happens If You Miss an Exemestane Dose?
If you miss a dose, follow the instructions provided by your healthcare professional or pharmacist.
Do not take extra tablets to compensate for a missed dose unless your healthcare professional specifically instructs you to do so.
Can You Stop Exemestane Suddenly?
Do not stop long-term cancer treatment without discussing it with your oncology team.
Stopping therapy can interrupt the intended treatment plan. If side effects become difficult to manage, your healthcare professional can evaluate possible alternatives.
How Long Is Exemestane Taken?
The duration depends on the cancer type, treatment history, and overall treatment plan.
For one approved early breast cancer setting, the U.S. label describes switching from tamoxifen after 2 to 3 years and continuing exemestane to complete a total of 5 consecutive years of adjuvant hormonal therapy.
Advanced breast cancer treatment can follow a different schedule. Therefore, never determine treatment duration solely from the package size.
What Is the Cost of Exemestane?
Exemestane cost varies according to brand, country, pharmacy, package size, prescription requirements, and availability.
Xtane 25mg is an Indian exemestane product marketed by Natco Pharma. Current Indian listings show a 30-tablet pack.
Prices can change frequently. Therefore, check the current price and availability before placing an order.
Is Xtane 25mg the Same as Aromasin?
Xtane 25mg and Aromasin contain the same active ingredient, exemestane, at the 25mg strength. However, they are different branded products.
Aromasin is the branded product described in the current U.S. FDA-approved labeling. Xtane is marketed by Natco Pharma in India.
Is Exemestane a Chemotherapy Medicine?
Exemestane is generally classified as an endocrine or hormone therapy, not traditional cytotoxic chemotherapy.
It works by reducing estrogen production rather than directly killing rapidly dividing cells in the way many traditional chemotherapy medicines do.
Frequently Asked Questions About Xtane 25mg
What is Xtane 25mg used for?
Xtane 25mg contains exemestane and is used in certain breast cancer treatment settings, particularly hormone-sensitive breast cancer after menopause.
What is exemestane?
Exemestane is a steroidal aromatase inhibitor that reduces estrogen production in the body.
What is the usual exemestane 25mg dose?
The U.S. Aromasin label recommends 25mg once daily after a meal for its approved indications. Individual treatment plans can differ.
Should exemestane be taken with food?
Yes. The U.S. label recommends taking exemestane after a meal. Food increases exemestane exposure and supports consistent absorption.
What are the most common exemestane side effects?
Common effects can include hot flashes, sweating, joint or muscle discomfort, headache, tiredness, sleep difficulties, and nausea.
Does exemestane cause bone loss?
It can. Lower estrogen levels can reduce bone mineral density. Therefore, healthcare professionals may monitor bone health during long-term treatment.
Is exemestane better than anastrozole?
Neither medicine is automatically better for every patient. Both are aromatase inhibitors, but the appropriate choice depends on the individual treatment plan.
Is exemestane the same as tamoxifen?
No. Tamoxifen blocks estrogen receptors, while exemestane reduces estrogen production by inhibiting aromatase.
Can exemestane be used during pregnancy?
Exemestane is not intended for use during pregnancy. People who are pregnant or may become pregnant should discuss treatment and contraception with their healthcare professional.
Is Xtane 25mg FDA approved?
The U.S. FDA-approved labeling cited on this page applies to Aromasin/exemestane and not automatically to the Xtane brand. Regulatory status can differ between countries.
U.S. Medical Information
The current U.S. prescribing information for Aromasin identifies exemestane as an aromatase inhibitor and lists 25mg tablets. Approved indications include specific early and advanced breast cancer settings in postmenopausal patients. The label also provides important information about bone health, drug interactions, pregnancy, and other precautions. :contentReference[oaicite:10]{index=10}
For additional authoritative information, review:
Explore More Products
Visit our medicine collection to explore additional products. You can also return to the IvermectinOnline.us homepage for more healthcare information and product categories.
Regulatory Information
Important: Xtane 25mg is an internationally marketed exemestane product. This page does not represent Xtane specifically as an FDA-approved U.S. brand. U.S. regulatory information cited here relates to exemestane and the FDA-approved U.S. product labeling for Aromasin.
Prescription, dispensing, importation, and use requirements vary by country and jurisdiction. Customers should verify applicable local requirements and consult a licensed healthcare professional before using prescription medicines.
Disclaimer
This information is provided for educational purposes only. It does not replace medical advice, diagnosis, or treatment from a qualified healthcare professional.
Xtane 25mg should be used only according to an appropriate prescription and professional guidance. Do not start, stop, or change cancer treatment based solely on information published on this page.
Reviews
There are no reviews yet.